How Much Does Tirzepatide Cost Out-of-Pocket?
Tirzepatide (brand name Mounjaro) is a next-generation injectable medication FDA-approved for type 2 diabetes and, in some cases, weight management. As with all new therapies, its cost is a major consideration for patients and clinicians. The typical list price for a 1-month supply ranges from $970–$1,100 USD depending on the dose and pharmacy, but your actual out-of-pocket cost could differ significantly.
- Without insurance: Expect to pay list price at most US pharmacies.
- With commercial insurance: Costs range from $25/month (with copay card) to over $500/month, based on coverage.
- Medicare & Medicaid: Coverage varies; many plans still list tirzepatide as non-formulary for weight loss.
It’s important to understand that insurance coverage often depends on your diagnosis. For type 2 diabetes, tirzepatide is more likely to be covered than for obesity or weight loss alone. Always check your policy’s formulary and seek documentation for prior authorization if needed.
What Affects Tirzepatide Pricing?
- Diagnosis: Insurance approval is stricter for weight loss than for diabetes
- Dosage: Higher doses may be the same sticker price, but a single pen may last fewer injections
- Pharmacy Choice: Prices vary across major chains and independent pharmacies
- Savings Programs: Manufacturer copay cards, pharmacy coupons, and patient assistance may lower costs
- Source: Some online or compounding pharmacies advertise lower prices, but FDA warnings and supply chain risks must be considered
For a medically rigorous comparison of GLP-1 medications—including tirzepatide—review our GLP-1 drug overview which details cost, mechanism, and efficacy.
Insurance Coverage: Diabetes vs. Obesity
Most US insurance plans categorize tirzepatide as a diabetes treatment. As a result:
- For type 2 diabetes: Coverage is common for commercial plans, though copay and prior-authorization policies vary.
- For weight loss/obesity: Coverage remains rare (less than 20% of employer plans as of 2024). Even when covered, requirements are strict: medical necessity documentation, high BMI, and failed prior therapies are often needed.
Medicare and Medicaid generally do not cover anti-obesity medications, including tirzepatide. Some patients look to compounding pharmacies for alternatives, but these are not FDA-approved for safety or effectiveness.
Ways to Save on Tirzepatide
- Manufacturer Savings Cards: If you have commercial insurance, the tirzepatide manufacturer offers savings cards that can reduce cost to as low as $25/month for qualifying patients.
- Pharmacy Coupons: Some pharmacy networks and online platforms provide limited-use coupons, but these may not combine with insurance.
- Patient Assistance Programs: For those who meet income and insurance requirements, patient assistance programs may provide medication at no or reduced cost.
- Compare Pharmacies: Prices can vary by hundreds of dollars between major pharmacy chains. Always compare several sources.
- Check Compounding Pharmacies Carefully: While some advertise lower prices, the FDA has issued warnings regarding the safety and legality of compounded tirzepatide. Always verify credentials and consult your provider.
For additional details on maximizing coverage and financial assistance, visit our obesity treatment and resources page.
How Tirzepatide’s Cost Compares to Other GLP-1 Medications
Tirzepatide’s price is similar to other leading GLP-1 receptor agonists. For example:
| Drug | Monthly Price (USD) | Insurance Coverage |
|---|---|---|
| Tirzepatide (Mounjaro) | $970–$1,100 | Diabetes: Yes; Obesity: Limited |
| Semaglutide (Ozempic/Wegovy) | $950–$1,350 | Diabetes: Yes; Obesity: Some |
| Liraglutide (Victoza/Saxenda) | $800–$1,100 | Diabetes: Yes; Obesity: Some |
In practice, out-of-pocket costs for all these therapies are highly dependent on your insurance, eligibility for assistance programs, and local pharmacy pricing.
What to Ask Your Provider
- Can my diagnosis support insurance approval for tirzepatide?
- What documentation is required for prior authorization?
- Can you help me with manufacturer savings or assistance programs?
- What is the titration plan and how does it affect cost?
- Are there safe, lower-cost alternatives I should consider?
Understanding the full cost landscape—and discussing options with an experienced clinician—can help you make the most informed, financially sound decision about tirzepatide treatment.